SCHEMBL20041689

SCHEMBL20041689

Cn1c2ccc(-c3ccccc3)cc2n2c3ccccc3nc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
HSD17B10 Q99714 5/20 0.44
NPSR1 Q6W5P4 1/20 0.44
KDM4E B2RXH2 6/20 0.43
ALDH1A1 P00352 6/20 0.43
TP53 P04637 5/20 0.43
HPGD P15428 4/20 0.43
GAA P10253 2/20 0.43
NPC1 O15118 2/20 0.43
PKM P14618 2/20 0.43
RAB9A P51151 2/20 0.43
ALOX15 P16050 2/20 0.43
RXFP1 Q9HBX9 2/20 0.42
ATM Q13315 1/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HTT P42858 1/20 0.41
GFER P55789 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17507390 1.00 MEN1 (0.44) MEN1KMT2AHSD17B10NPSR1KDM4E
SCHEMBL20041551 0.97 MEN1 (0.46) MEN1KMT2AHSD17B10NPSR1KDM4E
SCHEMBL20041554 0.96 MEN1 (0.43) MEN1KMT2AHSD17B10NPSR1KDM4E
SCHEMBL20041528 0.94 MEN1 (0.44) MEN1KMT2AHSD17B10NPSR1KDM4E
SCHEMBL20041525 0.94 MEN1 (0.44) MEN1KMT2AHSD17B10NPSR1KDM4E
SCHEMBL22926701 0.93 HSD11B1 (0.40) MEN1KMT2AHSD17B10NPSR1KDM4E
SCHEMBL20041687 0.92 THRB (0.47) MEN1KMT2AHSD17B10NPSR1KDM4E
SCHEMBL20041428 0.91 MAPT (0.50) MEN1KMT2AHSD17B10KDM4EALDH1A1
SCHEMBL21965199 0.90 ADORA1 (0.44) MEN1KMT2AHSD17B10NPSR1KDM4E
SCHEMBL20041691 0.89 MAPT (0.51) MEN1KMT2AHSD17B10KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11793073-B2 Host materials for electroluminescent devices UNIVERSAL DISPLAY CORPORATION (US) 2023-10-17 US disclosed
US-11793073-B2 Host materials for electroluminescent devices UNIVERSAL DISPLAY CORPORATION (US) 2023-10-17 US disclosed
US-20210028376-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2021-01-28 US disclosed
US-20200144512-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2020-05-07 US disclosed
EP-2982676-B1 Benzimidazo[2,1-B]benzoxazoles for electronic applications IDEMITSU KOSAN CO (JP) 2018-04-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11793073-B2 Host materials for electroluminescent devices MCM6, MCM2, MCM4 MEN1 438/4885KMT2A 3882/4885HSD17B10 3379/4885
US-20200144512-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES GDA, SOD1, GALC MEN1 3611/4885KMT2A 4198/4885HSD17B10 1862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.